ADAR2 can edit the mRNA of insulin-like growth factor binding protein 7 (IGFBP7) and change the protease recognition site of matriptase to stabilize IGFBP7 protein, thus stimulating the apoptosis of cancer cells. This evidence concerns the gene IGFBP7 and cancer.